Sowell Financial Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,190
| Closed | -$18K | – | 3193 |
|
|
2021
Q1 | $18K | Hold |
11,190
| – | – | ﹤0.01% | 2107 |
|
|
2020
Q4 | $24K | Sell |
11,190
-44
| -0.4% | -$94 | ﹤0.01% | 1668 |
|
|
2020
Q3 | $30K | Sell |
11,234
-100
| -0.9% | -$267 | ﹤0.01% | 1389 |
|
|
2020
Q2 | $45K | Buy |
11,334
+8,515
| +302% | +$33.8K | ﹤0.01% | 1190 |
|
|
2020
Q1 | $2K | Hold |
2,819
| – | – | ﹤0.01% | 2159 |
|
|
2019
Q4 | $4K | Hold |
2,819
| – | – | ﹤0.01% | 2029 |
|
|
2019
Q3 | $2K | Buy |
+2,819
| New | +$2K | ﹤0.01% | 2175 |
|
|
2019
Q1 | $9K | Buy |
+3,274
| New | +$9K | ﹤0.01% | 565 |
|
|
2018
Q4 | – | Sell |
-12,020
| Closed | -$55K | – | 557 |
|
|
2018
Q3 | $55K | Buy |
12,020
+1,530
| +15% | +$7K | 0.01% | 361 |
|
|
2018
Q2 | $29K | Sell |
10,490
-4,685
| -31% | -$13K | 0.01% | 294 |
|
|
2018
Q1 | $82K | Sell |
15,175
-10,157
| -40% | -$54.9K | 0.02% | 267 |
|
|
2017
Q4 | $190K | Sell |
25,332
-9,092
| -26% | -$68.2K | 0.05% | 245 |
|
|
2017
Q3 | $302K | Sell |
34,424
-40,949
| -54% | -$359K | 0.08% | 199 |
|
|
2017
Q2 | $593K | Sell |
75,373
-2,221
| -3% | -$17.5K | 0.17% | 119 |
|
|
2017
Q1 | $714K | Sell |
77,594
-1,332
| -2% | -$12.3K | 0.21% | 107 |
|
|
2016
Q4 | $667K | Buy |
+78,926
| New | +$667K | 0.22% | 100 |
|